Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway

Bicyclol, a synthetic hepatoprotective and anti-inflammatory agent approved in China, was widely used to treat various hepatitis accompanied by elevated serum aminotransferases. However, the pharmacological effects and mechanisms of bicyclol on advanced liver diseases, such as fibrosis/cirrhosis and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu Li, Nan-Nan Liu, Jian-Rui Li, Mei-Xi Wang, Jia-Li Tan, Biao Dong, Pei Lan, Li-Min Zhao, Zong-Gen Peng, Jian-Dong Jiang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-06-01
Colecção:Biomedicine & Pharmacotherapy
Assuntos:
Bicyclol
Advanced liver disease
Inflammation
Prevention and treatment
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S0753332222004723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados